| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals, Inc. | President and CEO, Director | Common Stock | 115,200 | $722,961 | $6.28 | 09 Dec 2022 | Direct |
| Reneo Pharmaceuticals, Inc. | President and CEO, Director | Stock option (right to buy) | 300,000 | 09 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | 09 Dec 2022 | 1 | $0 | 4 | President and CEO, Director | 13 Dec 2022, 17:09 |
| OKUR | Reneo Pharmaceuticals, Inc. | 10 Dec 2021 | 2 | $0 | 4 | President and CEO, Director | 14 Dec 2021, 15:31 |
| OKUR | Reneo Pharmaceuticals, Inc. | 25 Aug 2021 | 1 | +$64,000 | 4 | President and CEO, Director | 26 Aug 2021, 17:52 |